The online version of this article (doi:10.1186/1477-7819-10-4) contains supplementary material, which is available to authorized users.
The authors declare that they have no competing interests.
HSP contributed mainly in the design, literature review and writing of the article. Collection and assembly of the data was performed by BJC and HSP. BJS provided the idea, planned, edited and approved the written work. SK, KK, HY, BJC, JSB, and SSJ gave valuable advices and edited the discussion. Both BJS and SSJ also provided administrative supports. All authors read and approved the manuscript.
Distant recurrence is one of the most important risk factors in overall survival, and distant recurrence is related to a complex biologic interaction of seed and soil factors. The aim of the study was to investigate the association between the molecular subtypes and patterns of distant recurrence in patients with breast cancer.
In an investigation of 313 women with breast cancer who underwent surgery from 1994 and 2000, the expressions of estrogen and progestrone receptor (ER/PR), and human epithelial receptor-2 (HER2) were evaluated. The subtypes were defined as luminal-A, luminal-HER2, HER2-enriched, and triple negative breast cancer (TNBC) according to ER, PR, and HER2 status.
Bone was the most common site of distant recurrence. The incidence of first distant recurrence site was significantly different among the subtypes. Brain metastasis was more frequent in the luminal-HER2 and TNBC subtypes. In subgroup analysis, overall survival in patients with distant recurrence after 24 months after surgery was significantly different among the subtypes.
Organ-specific metastasis may depend on the molecular subtype of breast cancer. Tailored strategies against distant metastasis concerning the molecular subtypes in breast cancer may be considered.
Paget S: The distribution of secondary growths in cancer of the breast. 1889. Cancer Metastasis Rev. 1989, 8: 98-101. PubMed
Sorlie T, Perou CM, Tibshirani R, Aas T, Geisler S, Johnsen H, Hastie T, Eisen MB, van de Rijn M, Jeffrey SS: Gene expression patterns of breast carcinomas distinguish tumor subclasses with clinical implications. Proc Natl Acad Sci USA. 2001, 98: 10869-10874. 10.1073/pnas.191367098. PubMedCentralCrossRefPubMed
Spitale A, Mazzola P, Soldini D, Mazzucchelli L, Bordoni A: Breast cancer classification according to immunohistochemical markers: clinicopathologic features and short-term survival analysis in a population-based study from the South of Switzerland. Ann Oncol. 2009, 20: 628-635. 10.1093/annonc/mdn675. CrossRefPubMed
Meyers MO, Klauber-Demore N, Ollila DW, Amos KD, Moore DT, Drobish AA, Burrows EM, Dees EC, Carey LA: Impact of Breast Cancer Molecular Subtypes on Locoregional Recurrence in Patients Treated with Neoadjuvant Chemotherapy for Locally Advanced Breast Cancer. Ann Surg Oncol. 2011, 18 (10): 2851-7. 10.1245/s10434-011-1665-8. CrossRefPubMed
Kim SI, Sohn J, Koo JS, Park SH, Park HS, Park BW: Molecular Subtypes and Tumor Response to Neoadjuvant Chemotherapy in Patients with Locally Advanced Breast Cancer. Oncology. 2011, 79: 324-330. CrossRef
Zaha DC, Lazar E, Lazureanu C: Clinicopathologic features and five years survival analysis in molecular subtypes of breast cancer. Rom J Morphol Embryol. 2010, 51: 85-89. PubMed
Kuru B, Camlibel M, Dinc S, Gulcelik MA, Gonullu D, Alagol H: Prognostic factors for survival in breast cancer patients who developed distant metastasis subsequent to definitive surgery. Singapore Med J. 2008, 49: 904-911. PubMed
Kennecke H, McArthur H, Olivotto IA, Speers C, Bajdik C, Chia SK, Ellard S, Norris B, Hayes M, Barnett J, Gelmon KA: Risk of early recurrence among postmenopausal women with estrogen receptor-positive early breast cancer treated with adjuvant tamoxifen. Cancer. 2008, 112: 1437-1444. 10.1002/cncr.23320. CrossRefPubMed
Saphner T, Tormey DC, Gray R: Annual hazard rates of recurrence for breast cancer after primary therapy. J Clin Oncol. 1996, 14: 2738-2746. PubMed
Yuan ZY, Wang SS, Gao Y, Su ZY, Luo WB, Guan ZZ: [Clinical characteristics and prognosis of triple-negative breast cancer: a report of 305 cases]. Ai Zheng. 2008, 27: 561-565. PubMed
- Pattern of distant recurrence according to the molecular subtypes in Korean women with breast cancer
Hyung Seok Park
Byung Joo Chae
Ja Seong Bae
Byung Joo Song
Sang Seol Jung
- BioMed Central
Neu im Fachgebiet Chirurgie
Mail Icon II